MarketPulse — Real-Time Financial News & Market Analysis

FMC stock faces steep odds reaching $15 amid 5% revenue declines and weak profitability; strategic options being explored.

RMX Industries appoints VStock Transfer as new transfer agent, enhancing shareholder services and administrative infrastructure for the OTCQB-listed technology company.

Ark Invest's Cathie Wood dismisses quantum computing threats to Bitcoin as overstated, arguing quantum computers remain years away and post-quantum solutions are already in development.

Aethlon Medical's Hemopurifier device advances to final clinical trial phase following positive safety review with no adverse events reported.

Braemar Hotels declares monthly preferred dividends across four series, payable April 15, 2026, maintaining returns to preferred shareholders.

Pentagon rare earth ban by 2027 forces U.S. supply chain overhaul as China dominates critical processing capabilities essential for defense systems.

Corvex ($MOVE) distributes 35.8% special stock dividend to shareholders March 30, 2026, following merger agreement. AI infrastructure platform raises $40.2M.

Leatt Corporation reported 41% revenue growth to $61.9M and 248% net income surge to $3.26M in 2025, marking its sixth consecutive quarterly growth with strength across all product categories.

Hyperscale Data ($GPUS) holds 627.9 Bitcoin worth $42.6M, with combined cash and crypto assets representing 147% of market cap.

Law firm Holzer & Holzer announces April 6, 2026 lead plaintiff deadlines for class actions against TCPC, MREO, POM, and RARE over alleged material misstatements.

Shareholder lawsuits target Kyndryl and uniQure with lead plaintiff deadlines approaching April 2026. Investors must act quickly to join litigation.

Three shareholder lawsuits filed against $BRBR, $BYND, and $METC over alleged sales misstatements, asset valuations, and mine development disclosures. Lead plaintiff deadlines announced; affected investors encouraged to seek legal representation.

$IMNN to discuss 2025 results and OVATION 3 Phase 3 trial progress for IMNN-001 ovarian cancer immunotherapy on March 31, 2026.

China controls critical mineral processing with $120B invested since 2023, commanding 90% rare earth refining and raising Western supply chain vulnerabilities.

Super Micro ($SMCI) crashed 33% after export indictments, but company wasn't charged and shows 123% revenue growth. Analysts see 97% upside potential.

AMD trades 30% off peaks with bullish setup ahead of Q1 2026 earnings, as MI450 GPUs offer 200-400% upside potential in AI inference markets.

Manulife Investments announces March 2026 ETF distributions for 24 funds, with payouts to unitholders of record on April 15, 2026.

AerCap secures Boeing 777 freighter deal with Ethiopian Airlines for 2028 delivery, signaling confidence in cargo demand alongside 100 A320neo aircraft orders.

Five quality dividend stocks—yielding 5% to 7.1%—offer attractive passive income as market declines create opportunities for income-focused investors.

$ABBV and $BMY deliver above-average dividend yields and growth, standing out as rare healthcare sector exceptions for patient income investors navigating patent cliffs through innovation.